Meal-regulated Substrate Metabolism, Influence of Obesity and IL-6

NCT04687540 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Healthy

Interventions

DRUG: Tocilizumab
DRUG: Saline 0.9%

Sponsor

Rigshospitalet, Denmark